drug label

European Public Assessment Reports (EPARs) for drugs published by the European Medicines Agency (EMA) that include pgx information are now available to view on PharmGKB. We add any pgx-containing EMA or FDA drug labels that come to our attention. Like our FDA drug label information, we provide a summary and

The FDA approved a new drug for HER2 (ERBB2) positive breast cancer (June 8, 2012). Pertuzumab (Perjeta) is an antibody that targets a different epitope than trastuzumab (Herceptin), the first HER2 targeted antibody drug. The two drugs can therefore be combined to improve efficacy, and this was shown quite successfully